Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)
Funding Opportunity PA-19-112 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages collaborative applications that will contribute to the identification and characterization of patients at risk of developing cancer treatment-related cardiotoxicity. The primary intent is to mitigate cardiovascular dysfunction while optimizing cancer outcomes. To accomplish this, methods that evaluate cardiovascular risk prior to treatment and integrate evidence-based cancer treatment regimens with cardiovascular screening, diagnostic, and/or management strategies are sought. Research applicati...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 17, 2018 Category: Research Source Type: funding

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)
Funding Opportunity PA-19-111 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages collaborative applications that will contribute to the identification and characterization of patients at risk of developing cancer treatment-related cardiotoxicity. The primary intent is to mitigate cardiovascular dysfunction while optimizing cancer outcomes. To accomplish this, methods that evaluate cardiovascular risk prior to treatment and integrate evidence-based cancer treatment regimens with cardiovascular screening, diagnostic, and/or management strategies are sought. Research applicati...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 17, 2018 Category: Research Source Type: funding

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
Funding Opportunity PAR-19-113 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology. The projects supported by this FOA will establish and collectively participate in the Cancer Tissue Engineering Collab...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 17, 2018 Category: Research Source Type: funding

Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-104 from the NIH Guide for Grants and Contracts. As part of the Gabriella Miller Kids First Pediatric Research Program (Kids First), the NIH invites applications to submit samples from pediatric cohorts for whole genome sequencing at a Kids First-supported sequencing center. Applicants are encouraged to propose sequencing of existing pediatric cancer cohorts to elucidate the genetic contribution to childhood cancers, or to expand the range of disorders included within the Kids First Data Resource to investigate the genetic etiology of structural birth defects. Whole genome, exome, and transcript...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 14, 2018 Category: Research Source Type: funding

Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)
Funding Opportunity PAR-19-101 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites U01 cooperative agreement applications for Physical Science-Oncology Projects (PS-OP). The goal of the PS-OPs is to foster the convergence of physical sciences approaches and perspectives with cancer research to advance our understanding of cancer biology and oncology by forming small transdisciplinary teams of physical scientists and cancer biologists/physician-scientists. Examples of physical scientists may include engineers, physicists, mathematicians, chemists, and computer scientists. The PS...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 12, 2018 Category: Research Source Type: funding

Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)
Grants for research that examines how health information technology adoption impacts minority health and health disparity populations in access to care, quality of care, patient engagement, and health outcomes. Geographic coverage: Nationwide -- National Cancer Institute, National Institute on Minority Health and Health Disparities, National Institutes of Health, Office of Behavioral and Social Sciences Research, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - December 11, 2018 Category: American Health Source Type: funding

U.S.-Brazil Collaborative Biomedical Research Program (R01 Clinical Trial Optional)
Funding Opportunity RFA-AI-18-054 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote collaborative biomedical research between the United States and Brazil under the U.S.-Brazil Biomedical Collaborative Research Program. Research areas supported under this program include allergy, immunology, and infectious diseases, including HIV/AIDS and its co-morbidities; cancer; mother-to-child transmission of HIV and other congenital infections, early infant diagnosis and treatment; HIV/AIDS in relation to mental health; and neurological disorders and stroke. (Source...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 4, 2018 Category: Research Source Type: funding

Notice of a Pre-Application Webinar for RFA-CA-19-005 and RFA-CA-19-006 on Implementation Science for Cancer Control (Developing and Advanced Centers, respectively)
Notice NOT-CA-19-013 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 21, 2018 Category: Research Source Type: funding

Notice of Amendment of PA-17-211, Nutrition and Alcohol-Related Health Outcomes (R01), to Describe Specific Interests of the National Cancer Institute
Notice NOT-CA-19-012 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 20, 2018 Category: Research Source Type: funding

Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed)
Funding Opportunity PAR-19-069 from the NIH Guide for Grants and Contracts. REISSUE of PAR-18-733 The NIH Common Fund has established the Gabriella Miller Kids First Pediatric Research Program (Kids First) to develop a pediatric research data resource populated by genome sequence and phenotype data that will be of high value for the communities of investigators who study the genetics of childhood cancers and/or structural birth defects. The overall goal of the Gabriella Miller Kids First Pediatric Data Resource is to help researchers understand the underlying mechanisms of these conditions, leading to more refined diagnos...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 16, 2018 Category: Research Source Type: funding

Request for Proposals (RFP) N01CN87006-18 "PREVENT Cancer Preclinical Drug Development Program: cGMP Production of Vaccines and Biologicals for Cancer Prevention"
Notice NOT-CA-19-011 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 15, 2018 Category: Research Source Type: funding

Implementation Science for Cancer Control: Developing Centers (P50 Clinical Trial Optional)
Funding Opportunity RFA-CA-19-005 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to promote the creation of developing research centers that can build capacity to study high priority areas of cancer control implementation science, build implementation laboratories, improve the state of measurement and methods, and improve the adoption, implementation, and sustainment of evidence-based cancer control interventions. Specifically, this FOA targets the following areas designated as scientific priorities by the Blue Ribbon Panel (BRP): Prevention and Screening: Implementation of Evidence-based Approach...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 15, 2018 Category: Research Source Type: funding

Implementation Science for Cancer Control: Advanced Centers (P50 Clinical Trial Optional)
Funding Opportunity RFA-CA-19-006 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to promote the development of advanced research centers that can build capacity to study high priority areas of cancer control implementation science, build implementation laboratories, improve the state of measurement and methods, and improve the adoption, implementation, and sustainment of evidence-based cancer control interventions. Specifically, this FOA targets the following areas designated as scientific priorities by the Blue Ribbon Panel (BRP): Prevention and Screening: Implementation of Evidence-based Approac...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 15, 2018 Category: Research Source Type: funding

NCI Request for Information (RFI): Input to Advance Computational Approaches in Cancer Prevention Science
Notice NOT-CA-19-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 14, 2018 Category: Research Source Type: funding

TEAM Training to Support Equitable, Accessible, and Patient-Centered Cancer Care
Training that provides guidance, tools, and resources to help individuals and organizations implement quality improvements around patient-provider communication, health literacy, cultural sensitivity and shared decision-making. TEAM training will review a variety of factors that can impact health, and is appropriate for organizations looking to address rural health disparities. Geographic coverage: Nationwide -- George Washington University Cancer Center (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - November 13, 2018 Category: American Health Source Type: funding

Notice of Further Amendment of PAR-18-919 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)"
Notice NOT-CA-19-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 7, 2018 Category: Research Source Type: funding

Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3 Clinical Trial Required)
Funding Opportunity RFA-CA-19-018 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. This purpose of this FOA is to promote research in colorectal cancer (CRC) screening, follow-up, and referral-to-care among target populations for whom screening rates are below national standards. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Prevention and Screening: Implementation of Evidence-based approaches. The Acce...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 1, 2018 Category: Research Source Type: funding

Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-19-015 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research to accelerate the discovery of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 31, 2018 Category: Research Source Type: funding

Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-19-014 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. The goal of the network is to foster collaborative team science approaches to accelerate the discovery of new immune targets and evaluate ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 31, 2018 Category: Research Source Type: funding

Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-19-013 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research to accelerate the discovery of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 31, 2018 Category: Research Source Type: funding

Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3)
Funding Opportunity RFA-CA-19-012 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to support UG3/UH3 phased award Projects as part of the expanded Immuno-Oncology Translational Network (IOTN). The IOTN will form an integrated network of multi-disciplinary, collaborative teams with the overarching goals of accelerating translational research of innate and adaptive immune mechanisms that contribute to tumor initiation and progression and evaluating...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 31, 2018 Category: Research Source Type: funding

Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl Clinical Trial Not Allowed)
Funding Opportunity PA-19-035 from the NIH Guide for Grants and Contracts. The Center to Reduce Cancer Health Disparities (CRCHD) of the National Cancer Institute (NCI), in partnership with the NCI Office of Cancer Centers (OCC), announces this opportunity to compete for administrative supplements to Cancer Center Support Grants (CCSGs; P30s) for NCI-designated Cancer Centers (CCs) to each recruit a Community Health Educator (CHE). The purpose of this administrative supplement funding opportunity is to support a strengthening of community outreach capacity by working through the National Outreach Network (NON). It is expe...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 24, 2018 Category: Research Source Type: funding

Presolicitation Notice: Request for Proposals (RFP) N01CN87006-18 "PREVENT Cancer Preclinical Drug Development Program: cGMP Production of Vaccines and Biologicals for Cancer Prevention"
Notice NOT-CA-19-004 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 23, 2018 Category: Research Source Type: funding

Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 and R21)
Grants to support exploratory, developmental, and multidisciplinary research to understand the underlying causal factors and mechanisms that result in lung cancer disparities in U.S. health disparity populations. Geographic coverage: Nationwide -- National Cancer Institute, National Institute on Minority Health and Health Disparities, National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - October 18, 2018 Category: American Health Source Type: funding

Lymphatics in Health and Disease in the Digestive System (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-18-021 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to invite applications that investigate aspects of lymphatic vessel physiology, development and pathophysiology related to health and diseases of the digestive system. Studies to understand the factors that control local lymphatic vessel functional anatomy and physiology and development during health or disease in this system and its organs, and the mechanisms by which alterations of lymphatic vessel function affect organ function, are of interest. However, studies with the major focus on immune mechanisms, role of ly...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 16, 2018 Category: Research Source Type: funding

Lymphatics in Health and Disease in the Digestive System (R01 Clinical Trial Not Allowed)
The purpose of this FOA is to invite applications that investigate aspects of lymphatic vessel physiology, development and pathophysiology related to health and diseases of the digestive system. Studies to understand the factors that control local lymphatic vessel functional anatomy and physiology and development during health or disease in this system and its organs, and the mechanisms by which alterations of lymphatic vessel function affect organ function, are of interest. However, studies with the major focus on immune mechanisms, role of lymphatics in cancer metastasis and study of lymphatic vessels in organs other tha...
Source: NIDDK Funding Opportunities - October 16, 2018 Category: Endocrinology Source Type: funding

Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to PAR-18-303 Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed)
Notice NOT-CA-19-002 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 15, 2018 Category: Research Source Type: funding

Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to PAR-18-801 Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)
Notice NOT-CA-19-003 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 15, 2018 Category: Research Source Type: funding

Request for Information (RFI): Challenges and Opportunities for Understanding and Treating Small Cell Lung Cancer
Notice NOT-CA-19-001 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 10, 2018 Category: Research Source Type: funding

Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-019 from the NIH Guide for Grants and Contracts. This initiative will support exploratory and developmental multidisciplinary research to understand the underlying causal factors and mechanisms that result in lung cancer disparities in U.S. health disparity populations. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 5, 2018 Category: Research Source Type: funding

Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-018 from the NIH Guide for Grants and Contracts. This initiative will support multidisciplinary research to understand the underlying causal factors and mechanisms that result in lung cancer disparities in U.S. health disparity populations. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 5, 2018 Category: Research Source Type: funding

Notice of a Pre-Application Webinar for RFA-CA-19-016 "Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54)"
Notice NOT-CA-18-110 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2018 Category: Research Source Type: funding

Notice of Change to Application Types Allowed for PAR-18-919 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)"
Notice NOT-CA-18-109 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2018 Category: Research Source Type: funding

Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl - Clinical Trial Not Allowed)
Funding Opportunity PAR-18-931 from the NIH Guide for Grants and Contracts. The Center to Reduce Cancer Health Disparities (CRCHD) of the National Cancer Institute (NCI), in partnership with the NCI Office of Cancer Centers (OCC), announces this opportunity to compete for administrative supplements to Cancer Center Support Grants (CCSGs; P30s) for NCI-designated Cancer Centers (CCs) to each recruit a Community Health Educator (CHE). The purpose of this administrative supplement funding opportunity is to support a strengthening of community outreach capacity by working through the National Outreach Network (NON). It is exp...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2018 Category: Research Source Type: funding

The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
Funding Opportunity RFA-CA-19-002 from the NIH Guide for Grants and Contracts. The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the transition of talented graduate students into successful cancer research postdoctoral appointments, and provide opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers. ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 17, 2018 Category: Research Source Type: funding

Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)
Funding Opportunity RFA-CA-18-029 from the NIH Guide for Grants and Contracts. The purpose of this RFA is to support early clinical trials consortia poised to efficiently evaluate the biologic effects of cancer preventive agents and to determine clinically-relevant correlates in order to advance their development for cancer prevention. The program objectives are: To efficiently design and conduct early phase clinical trials to assess the cancer preventive potential of NCI-sponsored agents of varying classes, many of which target molecules or processes known to be important during carcinogenesis. These trials include phase...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 14, 2018 Category: Research Source Type: funding

Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Coordinating Center (DMACC) (U24 Clinical Trials Required)
Funding Opportunity RFA-CA-18-030 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is a part of the National Cancer Institute (NCI) initiative intended to support Cancer Prevention Clinical Trials Network (CP-CTNet). The goals for the CP-CTNet include: Design and conduct early phase clinical trials to assess the safety, tolerability, and cancer preventive potential of agents and interventions of varying classes, many of which target molecules or processes known to be important during carcinogenesis. These trials include phase 0 (microdosing), phase I (dose-finding), and phase II (pr...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 14, 2018 Category: Research Source Type: funding

Notice of Change to Key Dates in PAR-18-249 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)"
Notice NOT-CA-18-093 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 13, 2018 Category: Research Source Type: funding

Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-919 from the NIH Guide for Grants and Contracts. This purpose of this Funding Opportunity Announcement (FOA) is to provide a mechanism of support to research organizations interested in clinically translating already optimized quantitative imaging software tools capable of measuring or predicting the response of cancer to clinical therapies, or in translating imaging software tools for planning and validating radiation therapy treatment strategies in clinical trials. The quantitative software tools must have been developed and optimized during a performance period in the Quantitative Imaging Net...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 12, 2018 Category: Research Source Type: funding

Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-19-016 from the NIH Guide for Grants and Contracts. The FOA will focus on fusion oncoproteins found in tumors that have high risk of treatment failure and for which there has been little progress in identifying targeted agents. Responsive applications can focus on any fusion oncoprotein in pediatric solid tumors or on NUP98 fusion proteins that occur in young children with acute myelogenous leukemia (AML). However, greater preference will be given to applications focused on PAX-FOXO (alveolar rhabdomyosarcoma), C11orf95RELA (ependymoma), or NUP98 fusion proteins. (Source: NIH Funding Opportuniti...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 11, 2018 Category: Research Source Type: funding

Communication and Decision Making for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Optional).
Funding Opportunity RFA-CA-19-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative (https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative) that is intended to accelerate cancer research. The purpose of this FOA is to develop, test, and evaluate interventions and implementation approaches, or adapt existing approaches, to improve patient/provider/family risk communication and decision making for individuals and families with an inherited susceptibility to cancer. Specifically, this FOA targets the fol...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 10, 2018 Category: Research Source Type: funding

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-913 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Availa...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 7, 2018 Category: Research Source Type: funding

Notice of Termination of PAR-16-138 "Cancer Research Education Grants Program to Promote Diversity - Research Experiences (R25)"
Notice NOT-CA-18-105 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 7, 2018 Category: Research Source Type: funding

Notice of Termination of PAR-16-139 "Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25)"
Notice NOT-CA-18-106 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 7, 2018 Category: Research Source Type: funding

Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-911 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites P20 planning grant applications for developing collaborative partnership between institutions serving underserved health disparity populations and underrepresented students (ISUPS) and NCI- designated Cancer Centers (or Cancer Centers with highly integrated cancer research programs). This FOA is designed to facilitate the planning and execution of focused collaborations in cancer-related research, research experience, and research education. A major go...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 5, 2018 Category: Research Source Type: funding

Notice of Change to Application Review Information in PAR-18-801 "Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)"
Notice NOT-CA-18-103 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 31, 2018 Category: Research Source Type: funding

Notice of Change to Application Review Information in PAR-18-802, "Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional)"
Notice NOT-CA-18-104 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 31, 2018 Category: Research Source Type: funding

Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers (U54 Clinical Trial Required)
Funding Opportunity RFA-CA-18-018 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to facilitate the design, conduct, and completion of clinical trials for improving prevention of human papillomavirus (HPV)-related cancers in human immunodeficiency virus (HIV)-infected individuals. To serve this goal, the FOA will support a network of international collaborative sites conducting meritorious and appropriately designed prevention clinical trials in the Latin American and Caribbean (LAC) region via a U54 Partnership Centers mechanism. Each proposed U54 Partnership Cen...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 28, 2018 Category: Research Source Type: funding

Improving Smoking Cessation Interventions among People Living with HIV (R01 and R21 Clinical Trial Optional)
Funding for research designed to optimize smoking cessation treatment among people living with HIV. Research may address the behavioral and sociocultural factors and conditions that are associated with cigarette smoking among people living with HIV and may also address smoking-related health disparities. Geographic coverage: Nationwide -- National Cancer Institute, National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - August 27, 2018 Category: American Health Source Type: funding

Notice of Correction to Key Dates for PAR-17-206 "Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01)"
Notice NOT-CA-18-097 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 23, 2018 Category: Research Source Type: funding